Keith Michael Gottesdiener

CIK 1615856 · See Remarks · last filed 2025-09-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$55.89M

Companies

4

Total Filings

36

Lifetime Open-Market Net

-$2.40M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SEPN Director $35.95 $0 1 2025-09-29
PRME See Remarks 2,361,078 $2.77 $6.55M $0 8 2025-05-12
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Director 32,830 $19.00 $623.8K $74.9K 9 2023-05-25
RYTM CEO & President 558,250 $88.38 $49.34M -$2.48M 17 2020-03-11

Recent Filings · Page 4 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-05-10 RYTM Exer (M) +3,000 $13.8K EDGAR
2018-04-09 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Buy (P) +1,171 $74.9K EDGAR
2018-02-16 RYTM Grant (A) $0 EDGAR
2017-10-10 RYTM Conv (C) +27,262 $0 EDGAR
2017-06-29 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +1,423 $0 EDGAR
2016-07-21 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +2,407 $0 EDGAR
Showing 3136 of 36
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.